Novozymes A/S (OTCMKTS:NVZMY) Stock Crosses Below Two Hundred Day Moving Average – Should You Sell?

Novozymes A/S (OTCMKTS:NVZMY)’s stock price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $63.12 and traded as low as $56.37. Novozymes A/S shares last traded at $56.58, with a volume of 17,813 shares traded.

Analysts Set New Price Targets

A number of research analysts have recently commented on NVZMY shares. Berenberg Bank raised shares of Novozymes A/S to a “strong-buy” rating in a research report on Tuesday, September 24th. Barclays upgraded Novozymes A/S to a “strong-buy” rating in a research report on Monday, November 18th. Finally, Citigroup cut Novozymes A/S from a “neutral” rating to a “sell” rating in a research report on Thursday, October 17th.

Novozymes A/S Stock Performance

The business’s 50 day moving average price is $58.85 and its 200-day moving average price is $63.12. The company has a market cap of $26.50 billion, a price-to-earnings ratio of 35.81, a PEG ratio of 3.87 and a beta of 0.87.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.